RESULTS

High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker (Cancer Sci, 2024)

In a groundbreaking global partnership with Osaka University, Japan, Dr. Hara delved into the intricacies of RNA methylation within fresh specimens and organoid cultures derived from pancreatic cancer. Through meticulous research, Dr. Hara unveiled the activation of pivotal cell signaling pathways crucial in cancer metastasis. His findings shed light on the significance of m6A-activated TCEAL8 mRNA as a pioneering marker gene implicated in the malignant progression of pancreatic cancer.